Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022

Francis Baumgartner, Constance Baer, Stefanos Bamopoulos, Edward Ayoub, Marietta Truger, Manja Meggendorfer, Miriam Lenk, Gregor Hoermann, Stephan Hutter, Heiko Müller, Wencke Walter, Martha-Lena Müller, Niroshan Nadarajah, Piers Blombery, Ulrich Keller, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach

Blood (2024) 143 (12): 1139–1156.

https://doi.org/10.1182/blood.2023021199

Published: 2024

Includes: Supplemental data

Journal Articles

Tumor necrosis factor α promotes clonal dominance of KIT D816V + cells in mastocytosis: role of survivin and impact on prognosis

Blood (2024) 143 (11): 1006–1017.

https://doi.org/10.1182/blood.2023020515

Published: 2024

Includes: Supplemental data

Journal Articles

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia

Blood (2023) 141 (13): 1640–1644.

https://doi.org/10.1182/blood.2022017249

Published: 2023

Includes: Supplemental data

Journal Articles

AML and MDS Classification According to Who 2022 and International Consensus Classification: Do We Invent a Babylonian Confusion of Languages?

Sandra Huber, Constance Baer, Stephan Hutter, Frank Dicker, Manja Meggendorfer, Christian Pohlkamp, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach, Gregor Hoermann

Blood (2022) 140 (Supplement 1): 555–556.

https://doi.org/10.1182/blood-2022-162326

Published: 2022

Journal Articles

Interplay of TP53 Allelic State, Blast Count and Karyotype on Survival of Patients with AML and MDS

Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 2073–2074.

https://doi.org/10.1182/blood-2022-159388

Published: 2022

Journal Articles

How Whole Genome and Transcriptome Sequencing (WGTS) Can Contribute to Unsolved Cases in Hematology That Have Undergone Extensive Standard Diagnostic Workup: A Prospective Head-to-Head Study

Marietta Truger, Manja Meggendorfer, Wencke Walter, Stephan Hutter, Constance Baer, Niroshan Nadarajah, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach

Blood (2022) 140 (Supplement 1): 7824–7825.

https://doi.org/10.1182/blood-2022-166129

Published: 2022

Journal Articles

RUNX1 Mutated AML and MDS: Similarities, Differences and Molecular Factors Leading to Disease Progression

Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 2990–2991.

https://doi.org/10.1182/blood-2022-159379

Published: 2022

Journal Articles

Myeloid Neoplasms with MYC -Positive Double Minutes, a Specific Subgroup?

Isolde Summerer, Wencke Walter, Manja Meggendorfer, Torsten Haferlach, Stephan Hutter, Niroshan Nadarajah, Constance Baer, Anna Stengel, Wolfgang Kern, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 9142–9143.

https://doi.org/10.1182/blood-2022-166102

Published: 2022

Journal Articles

Molecular Evolution of Ccus Already Follows the Same Rules As MDS Progression

Constance Baer, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Gregor Hoermann

Blood (2022) 140 (Supplement 1): 8598–8599.

https://doi.org/10.1182/blood-2022-162168

Published: 2022

Journal Articles

Delineation of Predictive Features of AML Patients with Recurrent Relapse Who Achieved Repeated Complete Remission after Multiple Re-Induction and Consolidation Therapies

Irene Graf, Georg Greiner, Karoline V. Gleixner, Susanne Herndlhofer, Gabriele Stefanzl, Paul Knöbl, Alexander Hauswirth, Manja Meggendorfer, Ulrich Jaeger, Constance Baer, Torsten Haferlach, Gregor Hoermann, Peter Valent, Wolfgang R. Sperr

Blood (2022) 140 (Supplement 1): 11634–11635.

https://doi.org/10.1182/blood-2022-162588

Published: 2022

Journal Articles

Novel Non-Coding, Coding and Structural Variants in Hairy Cell Leukemia from Whole Genome Transcriptome Sequencing

Piers Blombery, Wencke Walter, Stephan Hutter, Constance Baer, Maki Sakuma, Heiko Mueller, Simon Wu, Imogen R Caldwell, Wolfgang Kern, Manja Meggendorfer, Claudia Haferlach, Torsten Haferlach

Blood (2022) 140 (Supplement 1): 3546–3547.

https://doi.org/10.1182/blood-2022-163300

Published: 2022

Journal Articles

Detection of Novel Occult Germline Multi-Exon Deletions in Patients with DDX41 Familial Predisposition to Myeloid Malignancy

Anna Maierhofer, Lucy C Fox, Stephan Hutter, Constance Baer, Ella Thompson, Tamia Nguyen, Nicole Den Elzen, Robin J Filshie, Ing S Tiong, Niroshan Nadarajah, Manja Meggendorfer, Wolfgang Kern, Claudia Haferlach, Torsten Haferlach, Piers Blombery

Blood (2022) 140 (Supplement 1): 8676–8677.

https://doi.org/10.1182/blood-2022-163064

Published: 2022

Journal Articles

IDH2 mutations in Hematological Malignancies: Distribution, Hot Spots, Clonal Development and Identification of a Novel (cyto-)Genetically Defined Subgroup

Anna Stengel, Manja Meggendorfer, Wencke Walter, Constance Baer, Niroshan Nadarajah, Stephan Hutter, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 3405–3406.

https://doi.org/10.1182/blood-2022-158979

Published: 2022

Journal Articles

MDS Classification - Do We Still Have to Count Blasts?

Claudia Haferlach, Sandra Huber, Heiko Mueller, Constance Baer, Gregor Hoermann, Manja Meggendorfer, Stephan Hutter, Wolfgang Kern, Torsten Haferlach

Blood (2022) 140 (Supplement 1): 1130–1131.

https://doi.org/10.1182/blood-2022-162147

Published: 2022

Journal Articles

Risk Prediction in MDS: A Validation of the IPSS-M and Comparison to IPSS-R and to Two Other Personalized Prediction Tools

Constance Baer, Sandra Huber, Stephan Hutter, Manja Meggendorfer, Niroshan Nadarajah, Wencke Walter, Uwe Platzbecker, Katharina Götze, Wolfgang Kern, Torsten Haferlach, Gregor Hoermann, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 1128–1129.

https://doi.org/10.1182/blood-2022-159939

Published: 2022

Journal Articles

Detecting the Unusual without Compromising Diagnostic Accuracy - a Prospective WGS/Wts Pilot Study in Acute Leukemias Provided Additional Information for Diagnosis, Prognosis and Treatment

Manja Meggendorfer, Marietta Truger, Wencke Walter, Constance Baer, Stephan Hutter, Niroshan Nadarajah, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach

Blood (2022) 140 (Supplement 1): 4959–4960.

https://doi.org/10.1182/blood-2022-159428

Published: 2022

Journal Articles

Application of a Flow Cytometric Core Marker Set in the Diagnostic Workup of Patients with Suspected Myelodysplastic Syndromes

Elisabeth Weiß, Torsten Haferlach, Constance Baer, Manja Meggendorfer, Claudia Haferlach, Wolfgang Kern

Blood (2022) 140 (Supplement 1): 4067–4068.

https://doi.org/10.1182/blood-2022-165987

Published: 2022

Journal Articles

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Blood (2021) 138 (26): 2753–2767.

https://doi.org/10.1182/blood.2021013626

Published: 2021

Includes: Supplemental data

Journal Articles

FISH and WGS in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma - WGS Will Affect Future Treatment Decisions

Marietta Truger, Stephan Hutter, Manja Meggendorfer, K. Martin Kortuem, Niroshan Nadarajah, Wencke Walter, Constance Baer, Leo Rasche, Wolfgang Kern, Torsten Haferlach, Hermann Einsele, Claudia Haferlach

Blood (2021) 138 (Supplement 1): 397.

https://doi.org/10.1182/blood-2021-152412

Published: 2021

Journal Articles

Benchmarking of Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS) As Diagnostic Tools for the Genetic Characterization of Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) in Adults

Claudia Haferlach, Wencke Walter, Manja Meggendorfer, Anna Stengel, Constance Baer, Stephan Hutter, Niroshan Nadarajah, Heiko Müller, Wolfgang Kern, Torsten Haferlach

Blood (2021) 138 (Supplement 1): 273.

https://doi.org/10.1182/blood-2021-150260

Published: 2021

NARROW

Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022

Tumor necrosis factor α promotes clonal dominance of KIT D816V + cells in mastocytosis: role of survivin and impact on prognosis

Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia

AML and MDS Classification According to Who 2022 and International Consensus Classification: Do We Invent a Babylonian Confusion of Languages?

Interplay of TP53 Allelic State, Blast Count and Karyotype on Survival of Patients with AML and MDS

How Whole Genome and Transcriptome Sequencing (WGTS) Can Contribute to Unsolved Cases in Hematology That Have Undergone Extensive Standard Diagnostic Workup: A Prospective Head-to-Head Study

RUNX1 Mutated AML and MDS: Similarities, Differences and Molecular Factors Leading to Disease Progression

Myeloid Neoplasms with MYC -Positive Double Minutes, a Specific Subgroup?

Molecular Evolution of Ccus Already Follows the Same Rules As MDS Progression

Delineation of Predictive Features of AML Patients with Recurrent Relapse Who Achieved Repeated Complete Remission after Multiple Re-Induction and Consolidation Therapies

Novel Non-Coding, Coding and Structural Variants in Hairy Cell Leukemia from Whole Genome Transcriptome Sequencing

Detection of Novel Occult Germline Multi-Exon Deletions in Patients with DDX41 Familial Predisposition to Myeloid Malignancy

IDH2 mutations in Hematological Malignancies: Distribution, Hot Spots, Clonal Development and Identification of a Novel (cyto-)Genetically Defined Subgroup

MDS Classification - Do We Still Have to Count Blasts?

Risk Prediction in MDS: A Validation of the IPSS-M and Comparison to IPSS-R and to Two Other Personalized Prediction Tools

Detecting the Unusual without Compromising Diagnostic Accuracy - a Prospective WGS/Wts Pilot Study in Acute Leukemias Provided Additional Information for Diagnosis, Prognosis and Treatment

Application of a Flow Cytometric Core Marker Set in the Diagnostic Workup of Patients with Suspected Myelodysplastic Syndromes

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

FISH and WGS in Newly Diagnosed and Relapsed/Refractory Multiple Myeloma - WGS Will Affect Future Treatment Decisions

Benchmarking of Whole Genome Sequencing (WGS) and Whole Transcriptome Sequencing (WTS) As Diagnostic Tools for the Genetic Characterization of Acute Myeloid Leukemia (AML) and Acute Lymphoblastic Leukemia (ALL) in Adults

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only